Puerarin promotes osteogenesis and inhibits adipogenesis in vitro

Chinese Medicine (United Kingdom)

Volumn 8, Issue 1, 2013, Pages

  Wang, Nan ^a   Wang, Xinluan ^a,b   Cheng, Wenxiang ^a   Cao, Huijuan ^a   Zhang, Peng ^a   Qin, Ling ^a,b  

^a SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; BETA CATENIN; CALCIUM; CCAAT ENHANCER BINDING PROTEIN ALPHA; CHOLECYSTOKININ OCTAPEPTIDE; LIPID BINDING PROTEIN; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; OSTEOPROTEGERIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; PUERARIN; TRIACYLGLYCEROL;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; POSTMENOPAUSE OSTEOPOROSIS; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84883372361     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-8-17     Document Type: Article

References (53)

1. Lau RY, Guo X. A review on current osteoporosis research: with special focus on disuse bone loss. J Osteoporos 2011, 2011:293808. 3160709, 21876833.
2. Raisz LG. Pathogenesis of osteoporosis: concepts, conflict, and prospects. J Clin Invest 2005, 115:3318-3325. 10.1172/JCI27071, 1297264, 16322775.
3. Turner RT, Riggs BL, Spelsberg TC. Skeletal effects of estrogen. Endocr Rev 1994, 15:275-300.
4. Chow J, Tobias JH, Colston KW, Chambers TJ. Estrogen maintains trabecular bone volume in rats not only by suppression of bone-resorption but also by stimulation of bone-formation. J Clin Invest 1992, 89:74-78. 10.1172/JCI115588, 442821, 1729283.
5. Qu Q, Perälä-Heape M, Kapanen A, Dahllund J, Salo J, Väänänen HK, Härkönen P. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 1998, 22:201-209. 10.1016/S8756-3282(97)00276-7, 9514212.
6. Takano-Yamamoto T, Rodan GA. Direct effects of 17 beta-estradiol on trabecular bone in ovariectomized rats. Proc Natl Acad Sci USA 1990, 87:2172-2176. 10.1073/pnas.87.6.2172, 53648, 2315310.
7. Qu Q, Harkonen PL, Monkkonen J, Vaananen HK. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro. Bone 1999, 25:211-215. 10.1016/S8756-3282(99)00153-2, 10456387.
8. Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001, 161:1161-1172. 10.1001/archinte.161.9.1161, 11343439.
9. Branca F. Dietary phyto-oestrogens and bone health. Proc Nutr Soc 2003, 62:877-887. 10.1079/PNS2003309, 15018488.
10. Rong H, Stevens JF, Deinzer ML, Cooman LD, Keukeleire DD. Identification of isoflavones in the roots of Pueraria lobata. Planta Med 1998, 64:620-627. 10.1055/s-2006-957534, 17253303.
11. Overstreet DH, Lee YW, Rezvani AH, Pei YH, Criswell HE, Janowsky DS. Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. Alcohol Clin Exp Res 1996, 20:221-227. 10.1111/j.1530-0277.1996.tb01633.x, 8730211.
12. Zhang NB, Huang ZG, Cui WD, Ding BP. Effects of puerarin on expression of cardiac Smad3 and Smad7 mRNA in spontaneously hypertensive rat. J Ethnopharmacol 2011, 138:737-740. 10.1016/j.jep.2011.10.013, 22027447.
13. Wang Q, Wu T, Chen X, Ni J, Duan X, Zheng J, Qiao J, Zhou L, Wei J. Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev 2006, 19. CD004196.
14. Jiang RW, Lau KM, Lam HM, Yam WS, Leung LK, Choi KL, Waye MM, Mak TC, Woo KS, Fung KP. A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis. J Ethnopharmaco 2005, 96:133-138.
15. Wang X, Wu J, Chiba H, Umegaket K, Yamada K, Ishimi Y. Puerariae radix prevents bone loss in ovariectomized mice. J Bone Miner Metab 2003, 21:268-275. 10.1007/s00774-003-0420-z, 12928827.
16. Zhang MY, Qiang H, Yang HQ, Dang XQ, Wang KZ. In vitro and in vivo effects of puerarin on promotion of osteoblast bone formation. Chin J Integr Med 2012, 18:276-282. 10.1007/s11655-012-1056-4, 22457138.
17. Hwang YP, Kim HG, Hien TT, Jeong MH, Jeong TC, Jeong HG. Puerarin activates endothelial nitric oxide synthase through estrogen receptor-dependent PI3-kinase and calcium-dependent AMP-activated protein kinase. Toxicol Appl Pharmacol 2011, 257:48-58. 10.1016/j.taap.2011.08.017, 21884717.
18. Boergermann JH, Kopf J, Yu PB, Knaus P. Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells. Int J Biochem Cell Biol 2010, 42:1802-1807. 10.1016/j.biocel.2010.07.018, 20691279.
19. Bodine PV, Komm BS. Wnt signaling and osteoblastogenesis. Rev Endocr Metal Disord 2006, 7:33-39.
20. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74. 10.1126/science.276.5309.71, 9082988.
21. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147. 10.1126/science.284.5411.143, 10102814.
22. Verma S, Rajaratnam JH, Denton J, Hoyland JA, Byers RJ. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 2002, 55:693-698. 10.1136/jcp.55.9.693, 1769760, 12195001.
23. Kaplan FS, Shore EM. Progressive osseous heteroplasia. J Bone Miner Res 2000, 15:2084-2094. 10.1359/jbmr.2000.15.11.2084, 11092391.
24. Dang Z, Löwik CW. The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J Bone Miner Res 2004, 19:853-861. 10.1359/jbmr.040120, 15068509.
25. Picherit C, Coxam V, Bennetau-Pelissero C, Kati-Coulibaly S, Davicco MJ, Lebecque P, Barlet JP. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 2000, 130:1675-1681.
26. Rosalki SB, Foo AY, Burlina A, Prellwitz W, Stieber P, Neumeier D, Klein G, Poppe WA, Bodenmüller H. Multicenter evaluation of Iso-ALP test kit for measurement of bone alkaline phosphatase activity in serum and plasma. Clin Chem 1993, 39:648-652.
27. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005, 280:33132-33140. 10.1074/jbc.M500608200, 16043491.
28. Otto TC, Lane MD. Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol 2005, 40:229-242. 10.1080/10409230591008189, 16126487.
29. Ntambi JM, Young-Cheul K. Adipocyte differentiation and gene expression. J Nutr 2000, 130:3122S-3126S.
30. Wong R, Rabie B. Effect of puerarin on bone formation. Osteoarthritis Cartilage 2007, 15:894-899. 10.1016/j.joca.2007.02.009, 17379543.
31. Li H, Wang JH, Huang HL, Li B. Effect of puerarin combined with estradiol on bone tissues and bone metabolism in ovariectomized rats. Journal of Clinical Rehabilitative Tissue Engineering Research 2010, 14:8616-8619.
32. Nuttall ME, Gimble JM. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?. Bone 2000, 27:177-184. 10.1016/S8756-3282(00)00317-3, 10913909.
33. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA. Inhibition of adipogenesis by Wnt signaling. Science 2000, 289:950-953. 10.1126/science.289.5481.950, 10937998.
34. Li Y, He J, He X, Li Y, Lindgren U. Nampt expression increases during osteogenic differentiation of multi- and omnipotent progenitors. Biochem Biophys Res Commun 2013, 434:117-123. 10.1016/j.bbrc.2013.02.132, 23537654.
35. Tiyasatkulkovit W, Charoenphandhu N, Wongdee K, Thongbunchoo J, Krishnamra N, Malaivijitnond S. Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica. Phytomedicine 2012, 19:1147-1155. 10.1016/j.phymed.2012.07.010, 22951392.
36. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771. 10.1016/S0092-8674(00)80259-7, 9182764.
37. Kawai M, Rosen CJ. PPARγ: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 2010, 6:629-636. 10.1038/nrendo.2010.155, 3132113, 20820194.
38. Jones JR, Barrick C, Kim KA, Lindner J, Blondeau B, Fujimoto Y, Shiota M, Kesterson RA, Kahn BB, Magnuson MA. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA 2005, 102:6207-6212. 10.1073/pnas.0306743102, 556131, 15833818.
39. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998, 14:59-88. 10.1146/annurev.cellbio.14.1.59, 9891778.
40. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD, MacDougald OA. Regulation of Wnt signaling during adipogen esis. J Biol Chem 2002, 277:30998-31004. 10.1074/jbc.M204527200, 12055200.
41. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 2005, 102:3324-3329. 10.1073/pnas.0408742102, 552924, 15728361.
42. Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997, 11:3286-3305. 10.1101/gad.11.24.3286, 9407023.
43. Kikuchi A. Modulation of Wnt signaling by Axin and Axil. Cytokine Growth Factor Rev 1999, 10:255-265. 10.1016/S1359-6101(99)00017-9, 10647780.
44. Miller JR, Hocking AM, Brown JD, Moon RT. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 1999, 18:7860-7872.
45. Li XH, Zhang JC, Sui SF, Yang MS. Effects of genistein, daidzein and glycitein on the osteogenic and adipogenic differentiation of bone marrow stromal cells and on the adipogenic trans-differentiation of osteoblasts. Acta Pharmacol Sin 2005, 26:1081-1086. 10.1111/j.1745-7254.2005.00161.x, 16115375.
46. Cawthorn WP, Bree AJ, Yao Y, Du B, Hemati N, Martinez-Santibañez G, MacDougald OA. Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism. Bone 2012, 50:477-489. 10.1016/j.bone.2011.08.010, 3261372, 21872687.
47. Bhukhai K, Suksen K, Bhummaphan N, Janjorn K, Thongon N, Tantikanlayaporn D, Piyachaturawat P, Suksamrarn A, Chairoungdua A. A phytoestrogen diarylheptanoid mediates estrogen receptor/Akt/glycogen synthase kinase 3β protein-dependent activation of the Wnt/β-catenin signaling pathway. J Biol Chem 2012, 287:36168-36178. 10.1074/jbc.M112.344747, 22936801.
48. Magun R, Burgering BM, Coffer PJ, Pardasani D, Lin Y, Chabot J, Sorisky A. Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 1996, 137:3590-3593. 10.1210/en.137.8.3590, 8754791.
49. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 2003, 17:1352-1365. 10.1101/gad.1089403, 196068, 12782654.
50. Varea O, Arevalo MA, Garrido JJ, Garcia-Segura LM, Wandosell F, Mendez P. Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system. Steroids 2010, 75:565-569. 10.1016/j.steroids.2009.09.006, 19778547.
51. Zhang W, Liu CQ, Wang PW, Sun SY, Su WJ, Zhang HJ, Li XJ, Yang SY. Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet. Eur J Pharmacol 2010, 649:398-402. 10.1016/j.ejphar.2010.09.054, 20869961.
52. Yan LP, Chan SW, Chan AS, Chen SL, Ma XJ, Xu HX. Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sci 2006, 79:324-330. 10.1016/j.lfs.2006.01.016, 16472823.
53. Zhao Y, Zhou Y. Puerarin improve insulin resistance of adipocyte through activating Cb1 binding protein path. Chin J Integr Med 2012, 18:293-298. 10.1007/s11655-012-1058-2, 22457141.